Dianthus Therapeutics, Inc. /DE/ Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (6 lists). Names and jurisdictions are as filed.
- 2024-03-21: Subsidiary Legal Name; Jurisdiction State of Organization.
- 2024-03-21: Subsidiary Magenta Securities Corporation; Jurisdiction Massachusetts.
- 2024-03-21: Subsidiary Dianthus Therapeutics OpCo, Inc.; Jurisdiction Delaware.
- 2023-03-23: Subsidiary Legal Name; Jurisdiction State of Organization.
| Annual report filed | Subsidiary | Jurisdiction |
|---|
| 2024-03-21 | Legal Name | State of Organization |
|---|
| 2024-03-21 | Magenta Securities Corporation | Massachusetts |
|---|
| 2024-03-21 | Dianthus Therapeutics OpCo, Inc. | Delaware |
|---|
| 2023-03-23 | Legal Name | State of Organization |
|---|
| 2023-03-23 | Magenta Securities Corporation | Massachusetts |
|---|
| 2022-03-08 | Legal Name | State of Organization |
|---|
| 2022-03-08 | Magenta Securities Corporation | Massachusetts |
|---|
| 2021-03-03 | Legal Name | State of Organization |
|---|
| 2021-03-03 | Magenta Securities Corporation | Massachusetts |
|---|
| 2020-03-03 | Legal Name | State of Organization |
|---|
| 2020-03-03 | Magenta Securities Corporation | Massachusetts |
|---|
| 2019-03-19 | Legal Name | State of Organization |
|---|
| 2019-03-19 | Magenta Securities Corporation | Massachusetts |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|